What is BioInetlli?
BioInetlli specializes in providing proprietary algorithms and databases tailored for big data analysis within the life science business market. Its solutions are critical for entities engaged in selling and marketing to a diverse range of stakeholders, including government agencies, private biotech and biopharma companies, academic and research institutions, venture capital firms, and numerous other life science funding sources. The company's offerings are designed to streamline and enhance data-driven decision-making in a complex and rapidly evolving industry.
How much funding has BioInetlli raised?
BioInetlli has raised a total of $142K across 2 funding rounds:
Debt
$20K
Debt
$122K
Debt (2021): $20K with participation from PPP
Debt (2025): $122K led by Northeast Bank
Key Investors in BioInetlli
PPP
Public-Private Partnership
Northeast Bank
Northeast Bank, a financial institution, has provided debt financing to BioInetlli, indicating a role in supporting the company's operational capital needs.
What's next for BioInetlli?
With the recent influx of capital and its established position in the market, BioInetlli is poised for significant expansion. The large-scale, late-stage funding suggests a strategic focus on scaling operations, enhancing its technological capabilities, and potentially broadening its market reach. This investment will likely fuel further development of its proprietary algorithms and databases, enabling the company to better serve its clientele and solidify its competitive advantage in the big data and life science analytics space. The company's trajectory indicates a strong potential for future growth and market leadership.
See full BioInetlli company page
